Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.67B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 3 |
TE Connectivity
TEL
|
+$948M |
| 4 |
Tesla
TSLA
|
+$910M |
| 5 |
Boeing
BA
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Visa
V
|
+$1.5B |
| 4 |
Morgan Stanley
MS
|
+$1.27B |
| 5 |
Exelon
EXC
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Healthcare | 17.88% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
West Pharmaceutical
WST
$24.6B
| $2.18M | ﹤0.01% |
6,656
+99
| +2% | +$31.2K |
|
1477
Energy Recovery
ERII
$465M
| $2.15M | ﹤0.01% |
146,024
-130,887
| -47% | -$2.24M |
|
1478
Liquidia Corp
LQDA
$8.06B
| $2.12M | ﹤0.01% |
179,999
+76
| +0% | +$831 |
|
1479
iShares MSCI Emerging Markets ETF
EEM
$29.6B
| $2.11M | ﹤0.01% |
+50,355
| New | +$2.23M |
|
1480
General Mills
GIS
$19.1B
| $2.1M | ﹤0.01% |
32,921
-2,439
| -7% | -$164K |
|
1481
Franklin Resources
BEN
$17.8B
| $2.05M | ﹤0.01% |
100,975
+71,308
| +240% | +$1.5M |
|
1482
ResMed
RMD
$32.3B
| $2.05M | ﹤0.01% |
8,958
-50,968
| -85% | -$12.3M |
|
1483
Green Dot
GDOT
$743M
| $2.05M | ﹤0.01% |
+192,466
| New | +$2.12M |
|
|
VERV
1484
DELISTED
Verve Therapeutics
VERV
| $2.04M | ﹤0.01% |
361,498
+14,469
| +4% | +$81.6K |
|
1485
NetApp
NTAP
$37.1B
| $2.03M | ﹤0.01% |
17,461
+2,463
| +16% | +$301K |
|
1486
CNA Financial
CNA
$14.2B
| $2.02M | ﹤0.01% |
41,670
+619
| +2% | +$30.2K |
|
1487
DexCom
DXCM
$31.2B
| $2.01M | ﹤0.01% |
25,841
-5,672,673
| -100% | -$420M |
|
1488
iQIYI
IQ
$1.25B
| $2M | ﹤0.01% |
+994,172
| New | +$2.36M |
|
1489
Conagra Brands
CAG
$7.16B
| $2M | ﹤0.01% |
71,994
-1,297
| -2% | -$36.8K |
|
1490
Allison Transmission
ALSN
$10B
| $1.99M | ﹤0.01% |
18,456
+1,871
| +11% | +$204K |
|
1491
PUT
VanEck Semiconductor ETF
SMH
$72.1B
| $1.98M | ﹤0.01% |
7,861
+3,931
| +100% | +$975K |
|
1492
Fidelity National Financial
FNF
$13.7B
| $1.98M | ﹤0.01% |
35,223
+28,468
| +421% | +$1.71M |
|
|
PARA
1493
DELISTED
Paramount Global Class B
PARA
| $1.96M | ﹤0.01% |
187,453
+85,047
| +83% | +$914K |
|
|
ARTV
1494
Artiva Biotherapeutics
ARTV
$548M
| $1.95M | ﹤0.01% |
194,108
| – | – |
|
|
BBOT
1495
BridgeBio Oncology
BBOT
$708M
| $1.94M | ﹤0.01% |
184,590
-80
| -0% | -$842 |
|
|
CNTA
1496
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.93M | ﹤0.01% |
115,107
+14,494
| +14% | +$240K |
|
1497
IQVIA
IQV
$38.7B
| $1.92M | ﹤0.01% |
9,791
+1,106
| +13% | +$233K |
|
1498
PUT
State Street Financial Select Sector SPDR ETF
XLF
$58.5B
| $1.91M | ﹤0.01% |
7,814,250
-2,616,750
| -25% | -$127M |
|
|
WBA
1499
DELISTED
Walgreens Boots Alliance
WBA
| $1.91M | ﹤0.01% |
204,979
+11,453
| +6% | +$106K |
|
1500
TG Therapeutics
TGTX
$7.55B
| $1.91M | ﹤0.01% |
63,513
-9,807
| -13% | -$281K |
|
Similar funds
Wellington Management Group's Q4 2024 Portfolio in Review
As of Q4 2024, Wellington Management Group held 2,066 positions worth $546B, down 4.3% from $571B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $25.7B in Q4 2024, closing 139 positions and reducing 894 holdings. Its most notable exit was Lineage Inc, an estimated $266M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in TE Connectivity worth $910M.
- Wellington Management Group's largest Q4 2024 buy was TE Connectivity: 6,362,160 shares worth $910M.
- Wellington Management Group added most to Eli Lilly in Q4 2024, an estimated $1.67B increase.
- Wellington Management Group's biggest Q4 2024 reduction was General Dynamics, cutting an estimated $1.7B.
- Wellington Management Group fully exited Lineage Inc in Q4 2024, selling an estimated $266M.
- Wellington Management Group's ten largest holdings make up 25% of its $546B portfolio in Q4 2024.
- Wellington Management Group opened 161 new positions and closed 139 in Q4 2024.
- Wellington Management Group's portfolio value fell 4.3% quarter-over-quarter to $546B.
Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.